Skip to content

Research at St Andrews

Meticillin-resistant Staphylococcus aureus with a novel mecA homologue in human and bovine populations in the UK and Denmark: a descriptive study

Research output: Contribution to journalArticle

Author(s)

Laura Garcia-Alvarez, Matthew Thomas Geoffrey Holden, Heather Lindsay, Cerian R. Webb, Derek F. J. Brown, Martin D. Curran, Enid Walpole, Karen Brooks, Derek J. Pickard, Christopher Teale, Julian Parkhill, Stephen D. Bentley, Giles F. Edwards, E. Kirsty Girvan, Angela M. Kearns, Bruno Pichon, Robert L. R. Hill, Anders Rhod Larsen, Robert L. Skov, Sharon J. Peacock & 2 others Duncan J. Maskell, Mark A. Holmes

School/Research organisations

Abstract

Background Animals can act as a reservoir and source for the emergence of novel meticillin-resistant Staphylococcus aureus (MRSA) clones in human beings. Here, we report the discovery of a strain of S aureus (LGA251) isolated from bulk milk that was phenotypically resistant to meticillin but tested negative for the mecA gene and a preliminary investigation of the extent to which such strains are present in bovine and human populations.

Methods Isolates of bovine MRSA were obtained from the Veterinary Laboratories Agency in the UK, and isolates of human MRSA were obtained from diagnostic or reference laboratories (two in the UK and one in Denmark). From these collections, we searched for mecA PCR-negative bovine and human S aureus isolates showing phenotypic meticillin resistance. We used whole-genome sequencing to establish the genetic basis for the observed antibiotic resistance.

Findings A divergent mecA homologue (mecA(LGA251)) was discovered in the LGA251 genome located in a novel staphylococcal cassette chromosome mec element, designated type-XI SCCmec. The mecA(LGA251) was 70% identical to S aureus mecA homologues and was initially detected in 15 S aureus isolates from dairy cattle in England. These isolates were from three different multilocus sequence type lineages (CC130, CC705, and ST425); spa type t843 (associated with CC130) was identified in 60% of bovine isolates. When human mecA-negative MRSA isolates were tested, the mecA(LGA251) homologue was identified in 12 of 16 isolates from Scotland, 15 of 26 from England, and 24 of 32 from Denmark. As in cows, t843 was the most common spa type detected in human beings

Interpretation Although routine culture and antimicrobial susceptibility testing will identify S aureus isolates with this novel mecA homologue as meticillin resistant, present confirmatory methods will not identify them as MRSA. New diagnostic guidelines for the detection of MRSA should consider the inclusion of tests for mecA(LGA251).

Close

Details

Original languageEnglish
Pages (from-to)595-603
Number of pages9
JournalLancet Infectious Diseases
Volume11
Issue number8
DOIs
Publication statusPublished - Aug 2011

    Research areas

  • CASSETTE CHROMOSOME MEC, LIVESTOCK-ASSOCIATED MRSA, TIME PCR ASSAY, METHICILLIN-RESISTANT, RAPID IDENTIFICATION, MULTIPLEX PCR, PREVALENCE, ELEMENT, NETHERLANDS, GUIDELINES

Discover related content
Find related publications, people, projects and more using interactive charts.

View graph of relations

Related by author

  1. Genomic identification of cryptic susceptibility to penicillins and β-lactamase inhibitors in methicillin-resistant Staphylococcus aureus

    Harrison, E. M., Ba, X., Coll, F., Blane, B., Restif, O., Carvell, H., Köser, C. U., Jamrozy, D., Reuter, S., Lovering, A., Gleadall, N., Bellis, K. L., Uhlemann, A. C., Lowy, F. D., Massey, R. C., Grilo, I. R., Sobral, R., Larsen, J., Rhod Larsen, A., Vingsbo Lundberg, C. & 5 othersParkhill, J., Paterson, G. K., Holden, M. T. G., Peacock, S. J. & Holmes, M. A., 24 Jun 2019, In : Nature Microbiology. 15 p.

    Research output: Contribution to journalArticle

  2. Atlas of group A streptococcal vaccine candidates compiled using large-scale comparative genomics

    Davies, M. R., McIntyre, L., Mutreja, A., Lacey, J. A., Lees, J. A., Towers, R. J., Duchêne, S., Smeesters, P. R., Frost, H. R., Price, D. J., Holden, M. T. G., David, S., Giffard, P. M., Worthing, K. A., Seale, A. C., Berkley, J. A., Harris, S. R., Rivera-Hernandez, T., Berking, O., Cork, A. J. & 18 othersTorres, R. S. L. A., Lithgow, T., Strugnell, R. A., Bergmann, R., Nitsche-Schmitz, P., Chhatwal, G. S., Bentley, S. D., Fraser, J. D., Moreland, N. J., Carapetis, J. R., Steer, A. C., Parkhill, J., Saul, A., Williamson, D. A., Currie, B. J., Tong, S. Y. C., Dougan, G. & Walker, M. J., Jun 2019, In : Nature Genetics. 51, 6, p. 1035-1043

    Research output: Contribution to journalArticle

  3. Antimicrobial resistance in atopic dermatitis: need for an urgent rethink

    Harkins, C. P., Holden, M. T. G. & Irvine, A. D., Mar 2019, In : Annals of Allergy Asthma & Immunology. 122, 3, p. 236-240 5 p.

    Research output: Contribution to journalArticle

  4. Molecular epidemiology and expression of capsular polysaccharides in Staphylococcus aureus clinical isolates in the United States

    Mohamed, N., Timofeyeva, Y., Jamrozy, D., Rojas, E., Hao, L., Silmon de Monerri, N. C., Hawkins, J., Singh, G., Cai, B., Liberator, P., Sebastian, S., Donald, R. G. K., Scully, I. L., Jones, C. H., Creech, C. B., Thomsen, I., Parkhill, J., Peacock, S. J., Jansen, K. U., Holden, M. T. G. & 1 othersAnderson, A. S., 14 Jan 2019, In : PLoS ONE. 14, 1, 33 p., e0208356.

    Research output: Contribution to journalArticle

Related by journal

  1. High-dose rifampicin, moxifloxacin, and SQ109 for treating tuberculosis: a multi-arm, multi-stage randomised controlled trial

    Boeree, M. J., Heinrich, N., Aarnoutse, R., Diacon, A. H., Dawson, R., Rehal, S., Kibiki, G. S., Churchyard, G., Sanne, I., Ntinginya, N. E., Minja, L. T., Hunt, R. D., Charalambous, S., Hanekom, M., Semvua, H. H., Mpagama, S. G., Manyama, C., Mtafya, B., Reither, K., Wallis, R. S. & 9 othersVenter, A., Narunsky, K., Mekota, A., Henne, S., Colbers, A., Plemper van Balen, G., Gillespie, S. H., Phillips, P. P. J. & Hoelscher, M., Jan 2017, In : Lancet Infectious Diseases. 17, 1, p. 39-49 11 p.

    Research output: Contribution to journalArticle

  2. Global initiative for meticillin-resistant Staphylococcus aureus pneumonia (GLIMP): an international, observational cohort study

    Aliberti, S., Reyes, L. F., Faverio, P., Sotgiu, G., Dore, S., Rodriguez, A. H., Soni, N. J., Restrepo, M. I., GLIMP investigators & Dhasmana, D. J., Dec 2016, In : Lancet Infectious Diseases. 16, 12, p. 1364-1376 13 p.

    Research output: Contribution to journalArticle

  3. New antituberculosis drugs, regimens, and adjunct therapies: needs, advances, and future prospects

    Zumla, A. I., Gillespie, S. H., Hoelscher, M., Philips, P. P. J., Cole, S. T., Abubakar, I., McHugh, T. D., Schito, M., Maeurer, M. & Nunn, A. J., Apr 2014, In : Lancet Infectious Diseases. 14, 4, p. 327-40 14 p.

    Research output: Contribution to journalArticle

  4. Chasing Koch's chimera

    Klatser, P., Anthony, R., Barry, C., Drobniewski, F., Hoffner, S., Niemann, S. & Gillespie, S., 1 Jan 2013, In : The Lancet Infectious Diseases. 13, 4, p. 289-291 3 p.

    Research output: Contribution to journalLetter

  5. Whole-genome sequencing for analysis of an outbreak of meticillin-resistant Staphylococcus aureus: a descriptive study

    Harris, S. R., Cartwright, E. J. P., Toeroek, M. E., Holden, M. T. G., Brown, N. M., Ogilvy-Stuart, A. L., Ellington, M. J., Quail, M. A., Bentley, S. D., Parkhill, J. & Peacock, S. J., Feb 2013, In : Lancet Infectious Diseases. 13, 2, p. 130-136 7 p.

    Research output: Contribution to journalArticle

ID: 74260982